Bristol-Myers Squibb
BMY
BMY
2,432 hedge funds and large institutions have $98.9B invested in Bristol-Myers Squibb in 2021 Q4 according to their latest regulatory filings, with 323 funds opening new positions, 859 increasing their positions, 1,005 reducing their positions, and 137 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,432
Holders Change
+147
Holders Change %
+6.43%
% of All Funds
37.56%
Holding in Top 10
64
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.99%
New
323
Increased
859
Reduced
1,005
Closed
137
Calls
$1.95B
Puts
$1.55B
Net Calls
+$401M
Net Calls Change
+$135M
Top Buyers
Top Sellers
| 1 |
Berkshire Hathaway
Omaha,
Nebraska
|
-$1.05B |
| 2 |
BlackRock
New York
|
-$456M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$442M |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
-$325M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$304M |